KalVista Pharmaceuticals, Inc.
Biotechnology · Healthcare
COO
2025-10-06–present
COO
KalVista Pharmaceuticals, Inc.
Equibles does not estimate personal net worth.
Bilal Arif is recorded as COO at KalVista Pharmaceuticals, Inc. since October 6, 2025. KalVista Pharmaceuticals, Inc. reported in an 8-K filed October 6, 2025 that Bilal Arif was appointed Chief Operating Officer, effective October 6, 2025. KalVista Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector.
“Effective October 6, 2025, the Board of Directors (the “Board”) of KalVista Pharmaceuticals, Inc. (the “Company”) appointed Bilal Arif as the Company’s Chief Operating Officer.”
KalVista Pharmaceuticals, Inc.
COO
SEC 8-K
2025-10-06–present
KalVista Pharmaceuticals, Inc.
Biotechnology · Healthcare
COO
2025-10-06–present